Acquired Factor V Inhibitor in a Cancer Patient: Failure of Immunosuppressive and Rituximab Treatment

Daniela Poli, Niccolò Maggini, Anna Paola Cellai, AgatinaAlessandrello Liotta, Fabio Pini, Annalisa Tognini and Elisa Grifoni
Additional contact information
AgatinaAlessandrello Liotta: Azienda Ospedaliero, Universitaria Careggi, Italy
Annalisa Tognini: Piombino, Azienda Sanitaria Nordovest, Italy
Elisa Grifoni: Department of Experimental and Clinical Medicine, University of Florence, Italy

Journal of Cardiology & Cardiovascular Therapy, 2017, vol. 5, issue 3, 38-40

Abstract: Acquired factor V inhibitor is a rare cause of factor V deficiency, with an overall good prognosis even if the clinical spectrum varies widely. Due to the rarity of the disease, there is scarce information on treatment that is mainly based on immunosuppressive agents.

Keywords: cardiology journal; scholarly articles on cardiology; cardiology citation report; cardiology citations; cardiology medical journals; free cardiology medical journals; cardiology journals; Cardiovascular Therapy; juniper publishers; juniper publishers open access journals (search for similar items in EconPapers)
Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/jocct/pdf/JOCCT.MS.ID.555662.pdf (application/pdf)
https://juniperpublishers.com/jocct/JOCCT.MS.ID.555662.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:ojocct:v:5:y:2017:i:3:p:38-40

DOI: 10.19080/JOCCT.2017.05.555662

Access Statistics for this article

Journal of Cardiology & Cardiovascular Therapy is currently edited by Sophia Mathis

More articles in Journal of Cardiology & Cardiovascular Therapy from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().